ZOTA: Zota Health Care Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2025
ZOTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 2.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Zota Health Care held its 25th AGM on September 29, 2025 via video conferencing. Shareholders approved a final dividend of 10% (Re. 1 per equity share) for FY25, an increase in authorised share capital, and a proposal to raise funds via Qualified Institutional Placement (QIP) of equity shares or equity-linked securities in one or more tranches. Remuneration revisions were approved for the Managing Director and four Whole-time/Executive Directors, along with material related party transactions involving its subsidiary Everyday Herbal Beauty Care. Operational highlights shared at the meeting show the retail pharmacy chain (Davaindia) grew to 1,582 stores (730 franchise + 852 company-operated) by Q4FY25, with FY25 total revenue of ₹18,621 lakhs, of which retail pharmacy contributed 64% and exports 22%.
The Re. 1 per share dividend is modest in absolute terms. The authorised QIP route signals potential equity dilution in the near term, which shareholders should watch closely. On the positive side, rapid retail store expansion (from 1,029 to 1,582 in one year) and strong revenue growth indicate healthy operational momentum.